Moderna to Present at Upcoming Conferences in May 2026

Rhea-AI Summary

Moderna (Nasdaq: MRNA) will present at three investor conferences in May 2026: BofA Securities Healthcare Conference on May 12, 2026 at 11:20 AM PT, PTRBC Global Healthcare Conference on May 19, 2026 at 10:00 AM ET, and Bernstein Strategic Decisions Conference on May 28, 2026 at 10:00 AM ET.

Live webcasts will be available in the Investors > Events and Presentations section at investors.modernatx.com, and replays will be archived for at least 30 days.

Argus Apr 21 session

-0.66% close to close Open Argus

Details

News Market Reaction – MRNA

In the Apr 21 session, MRNA declined 0.66%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement outlines a series of May 2026 investor conference appearances, with live webcasts ...

Analysis

This announcement outlines a series of May 2026 investor conference appearances, with live webcasts and 30-day replays. It follows recent catalysts, including EU regulatory progress for mCOMBRIAX, key vaccine data updates, and a major global patent settlement. Together, these events show active engagement with both regulators and investors. Market participants may watch for additional data, regulatory milestones, and capital allocation decisions discussed at these conferences.

Key Figures

BofA conference time: 11:20 am PT RBC conference time: 10:00 am ET Bernstein conference time: 10:00 am ET +1 more

BofA conference time

11:20 am PT

BofA Securities 2026 Healthcare Conference on May 12, 2026

RBC conference time

10:00 am ET

RBC 2026 Global Healthcare Conference on May 19, 2026

Bernstein conference time

10:00 am ET

Bernstein 42nd Strategic Decisions Conference on May 28, 2026

Webcast replay period

30 days

Minimum period replays remain archived on Moderna’s website

Historical Context

5 past events · Latest: Apr 17

5 events

1. Apr 17

   Oncology trial data

   24h Move

   -1.8%

   Phase 1/2 melanoma data with high ORR and FDA Fast Track designation.

2. Apr 15

   Earnings date set

   24h Move

   +2.7%

   Announcement of Q1 2026 earnings release and corporate update call.

3. Apr 06

   Vaccine data update

   24h Move

   +2.8%

   Revaccination data for flu vaccine mRNA-1010 and RSV vaccine mRESVIA.

4. Mar 03

   Patent settlement

   24h Move

   +16.0%

   Global settlement with Arbutus/Genevant and clarified cash/liquidity outlook.

5. Feb 27

   Regulatory opinion

   24h Move

   +3.6%

   EMA CHMP positive opinion for mCOMBRIAX combination vaccine in EU adults.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CAMBRIDGE, MA / ACCESS Newswire / April 21, 2026 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conferences:

BofA Securities 2026 Healthcare Conference, on Tuesday, May 12th at 11:20am PT

RBC 2026 Global Healthcare Conference, on Tuesday, May 19^th at 10:00 am ET

Bernstein's 42^nd Annual Strategic Decisions Conference, Thursday, May 28^th at 10:00am ET

A live webcast of each of these presentations will be available under "Events and Presentations" in the Investors section of the Moderna website at investors.modernatx.com.

A replay of each webcast will be archived on Moderna's website for at least 30 days following the presentation.

About Moderna

Moderna is a pioneer and leader in the field of mRNA medicine. Through the advancement of its technology platform, Moderna is reimagining how medicines are made to transform how we treat and prevent diseases. Since its founding, Moderna's mRNA platform has enabled the development of vaccines and therapeutics across infectious diseases, cancer, rare diseases and more.

With a global team and a unique culture, driven by the company's values and mindsets, Moderna's mission is to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X, Facebook, Instagram, YouTube and LinkedIn.

Moderna Contacts

Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
Lavina.Talukdar@modernatx.com

SOURCE: Moderna, Inc.

View the original press release on ACCESS Newswire

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Moderna (MRNA) present at the BofA Securities 2026 Healthcare Conference?

Moderna will present on May 12, 2026 at 11:20 AM PT. According to the company, a live webcast will be available via the Investors > Events and Presentations page, and a replay will be archived for at least 30 days after the presentation.

How can investors watch Moderna's (MRNA) PTRBC 2026 Global Healthcare Conference presentation?

Investors can watch a live webcast on the company's investor website. According to the company, the live webcast is on May 19, 2026 at 10:00 AM ET and a replay will remain archived for at least 30 days.

What time is Moderna (MRNA) speaking at Bernstein's 42nd Annual Strategic Decisions Conference?

Moderna is scheduled to present on May 28, 2026 at 10:00 AM ET. According to the company, the presentation will be webcast live on the Investors > Events and Presentations page and replayed for at least 30 days.

Where are Moderna (MRNA) conference webcasts hosted and how long are replays available?

Webcasts are hosted on Moderna's investor website under Events and Presentations. According to the company, each live webcast will be available there and replays will be archived for at least 30 days following each presentation.

Will Moderna (MRNA) provide replays for its May 2026 investor presentations and for how long?

Yes. According to the company, a replay of each webcast will be archived on Moderna's website for at least 30 days following the presentation, allowing investors to review content after the live events.